222 related articles for article (PubMed ID: 15162529)
81. HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo.
Dou Y; van Montfoort N; van den Bosch A; de Man RA; Zom GG; Krebber WJ; Melief CJM; Buschow SI; Woltman AM
J Infect Dis; 2018 Feb; 217(5):827-839. PubMed ID: 29220492
[TBL] [Abstract][Full Text] [Related]
82. CD8
Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
[TBL] [Abstract][Full Text] [Related]
83. Effects of CpG-ODNs on phenotype and function of monocyte-derived dendritic cells in chronic hepatitis B.
Xiang XX; Zhou XQ; Wang JX; Xie Q; Cai X; Yu H; Zhou HJ
World J Gastroenterol; 2011 Nov; 17(43):4825-30. PubMed ID: 22147985
[TBL] [Abstract][Full Text] [Related]
84. Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection.
Zheng PY; Zhang DY; Lu GF; Yang PC; Qi YM; Wang BS
World J Gastroenterol; 2007 Sep; 13(34):4641-5. PubMed ID: 17729422
[TBL] [Abstract][Full Text] [Related]
85. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
[TBL] [Abstract][Full Text] [Related]
86. The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication.
Sobao Y; Tomiyama H; Sugi K; Tokunaga M; Ueno T; Saito S; Fujiyama S; Morimoto M; Tanaka K; Takiguchi M
J Hepatol; 2002 Jan; 36(1):105-15. PubMed ID: 11804672
[TBL] [Abstract][Full Text] [Related]
87. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B.
Ma A; Motyka B; Gutfreund K; Shi YE; George R
Hum Vaccin Immunother; 2020 Apr; 16(4):756-778. PubMed ID: 31687879
[TBL] [Abstract][Full Text] [Related]
88. Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection.
Tavakoli S; Mederacke I; Herzog-Hauff S; Glebe D; Grün S; Strand D; Urban S; Gehring A; Galle PR; Böcher WO
Clin Exp Immunol; 2008 Jan; 151(1):61-70. PubMed ID: 18031557
[TBL] [Abstract][Full Text] [Related]
89. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
Lau GK; Suri D; Liang R; Rigopoulou EI; Thomas MG; Mullerova I; Nanji A; Yuen ST; Williams R; Naoumov NV
Gastroenterology; 2002 Mar; 122(3):614-24. PubMed ID: 11874993
[TBL] [Abstract][Full Text] [Related]
90. HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production.
Farag MMS; Suef RA; Al-Toukhy GM; Selim MA; Elbahnasawy MA; El Sharkawy N; Ezzat S; Shebl N; Mansour MTM
Infect Drug Resist; 2020; 13():2699-2709. PubMed ID: 32821133
[TBL] [Abstract][Full Text] [Related]
91. Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice.
Shi TD; Wu YZ; Jia ZC; Zhou W; Zou LY
World J Gastroenterol; 2004 Apr; 10(8):1222-6. PubMed ID: 15069731
[TBL] [Abstract][Full Text] [Related]
92. Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells.
De Pasquale C; Campana S; Barberi C; Sidoti Migliore G; Oliveri D; Lanza M; Musolino C; Raimondo G; Ferrone S; Pollicino T; Ferlazzo G
Hepatology; 2021 Aug; 74(2):550-565. PubMed ID: 33482027
[TBL] [Abstract][Full Text] [Related]
93. [PD-L1 expression in circulating dendritic cells of patients with chronic hepatitis B].
Peng GP; Sun W; Wu W; Sun Z; Tan XF; Li SP; Chen Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 37(4):364-72. PubMed ID: 18705009
[TBL] [Abstract][Full Text] [Related]
94. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.
Wentworth PA; Celis E; Crimi C; Stitely S; Hale L; Tsai V; Serra HM; Del Guercio MF; Livingston B; Alazard D; Fikes J; Kubo RT; Grey HM; Chesnut RW; Chisari FV; Sette A
Mol Immunol; 1995 Jun; 32(9):603-12. PubMed ID: 7643853
[TBL] [Abstract][Full Text] [Related]
95. Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B.
Lu GF; Tang FA; Zheng PY; Yang PC; Qi YM
World J Gastroenterol; 2008 Mar; 14(10):1617-21. PubMed ID: 18330958
[TBL] [Abstract][Full Text] [Related]
96. Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B.
Yu YS; Tang ZH; Han JC; Xi M; Feng J; Zang GQ
World J Gastroenterol; 2006 Mar; 12(9):1447-51. PubMed ID: 16552819
[TBL] [Abstract][Full Text] [Related]
97. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
[TBL] [Abstract][Full Text] [Related]
98. An immunodominant HLA-A*1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients.
Chen X; Wang W; Wang S; Meng G; Zhang M; Ni B; Wu Y; Wang L
J Gen Virol; 2013 Dec; 94(Pt 12):2717-2723. PubMed ID: 23997182
[TBL] [Abstract][Full Text] [Related]
99. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.
Nair SK; Hull S; Coleman D; Gilboa E; Lyerly HK; Morse MA
Int J Cancer; 1999 Jul; 82(1):121-4. PubMed ID: 10360830
[TBL] [Abstract][Full Text] [Related]
100. Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice.
Jiang W; Chen R; Kong X; Long F; Shi Y
Vaccine; 2014 Jul; 32(35):4565-4570. PubMed ID: 24951859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
